Request Legal Help Now - Free

LAWSUITS NEWS & LEGAL INFORMATION

Bravelle Infertility Drug Legal News Articles & Interviews

“The Bravelle Clock is Ticking,” Says Canadian Attorney

“The Bravelle Clock is Ticking,” Says Canadian Attorney September 4, 2017. By Jane Mundy.
Vancouver, BC: While plaintiffs, both in Canada and the U.S., are joining Bravelle Infertility drug lawsuits against manufacturer Ferring Pharmaceuticals, some couples and individuals have exhausted their finances due to the allegedly ineffective fertility drug. And time is not on their side.
Read [ “The Bravelle Clock is Ticking,” Says Canadian Attorney ]

Additional Plaintiffs Join Bravelle Class Action

Additional Plaintiffs Join Bravelle Class Action May 15, 2017. By Deb Hipp.
Chicago, IL: Attorneys representing plaintiffs in a class action against Ferring Pharmaceuticals concerning its infertility drug Bravelle have added more plaintiffs to the lawsuit, including an organization providing medical benefits and prescription drugs to Philadelphia city workers.
Read [ Additional Plaintiffs Join Bravelle Class Action ]

Federal Judge Extends Deadline to Add Parties to Bravelle Class Action

Federal Judge Extends Deadline to Add Parties to Bravelle Class Action March 15, 2017. By Deb Hipp.
Chicago, IL:An Illinois federal judge has extended until April the deadline to allow plaintiffs on a Bravelle class action to join additional parties to the lawsuit.
Read [ Federal Judge Extends Deadline to Add Parties to Bravelle Class Action ]

Federal Judge Dismisses Bravelle Lawsuit in Unusual Removal Situation

Federal Judge Dismisses Bravelle Lawsuit in Unusual Removal Situation February 14, 2017. By Deb Hipp.
Chicago, IL:A federal judge has dismissed a Bravelle lawsuit against Ferring Pharmaceuticals, the maker of Bravelle infertility drug, and Stericycle, the company that over saw the Bravelle recall, after plaintiff attorneys filed a motion to send the case back to state court.
Read [ Federal Judge Dismisses Bravelle Lawsuit in Unusual Removal Situation ]

A Renewed Shot at Justice for Bravelle Infertility Plaintiffs

A Renewed Shot at Justice for Bravelle Infertility Plaintiffs January 16, 2017. By Gordon Gibb.
Chicago, IL: The most recent news on the Bravelle lawsuit front continues to be the capacity for Bravelle litigants to continue their actions, following a failed bid last year by Ferring Pharmaceuticals Inc. to have the matter dismissed.
Read [ A Renewed Shot at Justice for Bravelle Infertility Plaintiffs ]

2017 Could Be a Big Year for Bravelle Litigation

2017 Could Be a Big Year for Bravelle Litigation December 16, 2016. By Heidi Turner.
Springfield, IL: It's been more than a year since the first Bravelle lawsuit was filed in the United States and a judge has recently ruled that Bravelle claims can move forward, meaning 2017 could be a big year for Bravelle litigation. The fertility treatment was voluntarily recalled in 2015 after reports emerged that the drug could lose its potency.
Read [ 2017 Could Be a Big Year for Bravelle Litigation ]

Bravelle Infertility Class Action Lawsuit Going Forward on Negligence Claims

Bravelle Infertility Class Action Lawsuit Going Forward on Negligence Claims November 17, 2016. By Gordon Gibb.
Chicago, IL: When the manufacturers of the Bravelle infertility drug temporarily recalled, and stopped selling the product a little more than a year ago over lack of potency, attorneys and legal professionals at the time predicted that plaintiffs would have a bit more of a challenging time bringing a Bravelle lawsuit given that there was no primary safety issue involved. To that end, any Bravelle Infertility Drug lawsuit brought since then has focused on the lack of quality and potency, rather than safety claims.
Read [ Bravelle Infertility Class Action Lawsuit Going Forward on Negligence Claims ]

Bravelle Lawsuit Survives Motion to Dismiss

Bravelle Lawsuit Survives Motion to Dismiss October 26, 2016. By Heidi Turner.
Chicago, IL: A Bravelle lawsuit has survived a motion from the defendants to dismiss, with a judge finding plaintiffs can revise their claims and file a second amended complaint. The lawsuit involves allegations that some women were given a batch of infertility drug—Bravelle—that had diminished potency and therefore decreased their chances of becoming pregnant.
Read [ Bravelle Lawsuit Survives Motion to Dismiss ]

One Couple’s Heartbreaking Bravelle Recall Story

One Couple’s Heartbreaking Bravelle Recall Story September 13, 2016. By Gordon Gibb.
Victoria, BC: It’s hard enough starting off in life lining up a career, a car, a house, paying off student debt and perhaps getting some investments going, not to mention planning a family. The latter could include starting a college fund, getting a baby’s room together, along with all the inherent costs associated with welcoming a new member of the family. For most, there is no cost associated with becoming pregnant. However for those with fertility issues, use of fertility drugs such as Bravelle often means the difference between successful conception, and being left childless. It would therefore come as no shock that those having paid handsomely for Bravelle fertility treatment have been left reeling from the Bravelle Recall.
Read [ One Couple’s Heartbreaking Bravelle Recall Story ]

Lawsuits Filed Over Weak Fertility Drug

Lawsuits Filed Over Weak Fertility Drug August 19, 2016. By Heidi Turner.
New York, NY: For some couples, Bravelle was their last chance at having a baby. The fertility drug, which is now the focus of lawsuits, offered hope to those who dream of having a baby but needed to undergo in vitro fertilization (IVF) treatment to make their dream a reality. IVF treatment isn't cheap, and some couples find they can only afford one round of treatment. So they were likely shocked to find out that the drug they pinned their last hopes on might not have been nearly as effective as they believed.
Read [ Lawsuits Filed Over Weak Fertility Drug ]


Request Legal Help Now! - Free